Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100μg vs Fluticasone Propionate 100μg in Adults and Adolescents with Asthma III: Results

@article{Johansson2012CostEffectivenessAO,
  title={Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100μg vs Fluticasone Propionate 100μg in Adults and Adolescents with Asthma III: Results},
  author={Gunnar Johansson and Dr Martin J. Price and Seema Sondhi},
  journal={PharmacoEconomics},
  year={2012},
  volume={16},
  pages={15-21}
}
Methods: An economic analysis was performed using data from a 12-week randomised controlled trial to determine the cost effectiveness of a salmeterol/fluticasone propionate combination product (SFC) 50/100μg twice daily (n = 86) relative to fluticasone propionate (FP) 100μg twice daily (n = 85) in adults and adolescents with asthma. The analysis was conducted from the perspective of the Swedish healthcare system. Results: SFC was associated with a significantly higher proportion of successfully… CONTINUE READING